200 related articles for article (PubMed ID: 35588265)
1. COVID-19 vaccine associated cervical lymphadenopathy: a case series.
Heaven CL; Barber L; Ahmadi O; Selvarajah K; Shetty S
ANZ J Surg; 2022 Sep; 92(9):2286-2291. PubMed ID: 35588265
[TBL] [Abstract][Full Text] [Related]
2. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 post-vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy.
Tan NJH; Tay KXJ; Wong SBJ; Nga ME
Diagn Cytopathol; 2021 Dec; 49(12):E467-E470. PubMed ID: 34432391
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
5. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.
Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K
AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774
[No Abstract] [Full Text] [Related]
6. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
7. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
8. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study.
Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM
Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107
[TBL] [Abstract][Full Text] [Related]
9. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
10. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
[TBL] [Abstract][Full Text] [Related]
11. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
12. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic - a follow up audit.
Mitchell OR; Couzins M; Dave R; Bekker J; Brennan PA
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):720-721. PubMed ID: 33947605
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA
Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M
Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Axillary Lymph Nodes on Breast MRI Before and After COVID-19 Booster Vaccination.
Parikh R; Feigin KN; Sevilimedu V; Huayanay J; Pinker K; Horvat JV
Acad Radiol; 2024 Mar; 31(3):755-760. PubMed ID: 37037711
[TBL] [Abstract][Full Text] [Related]
17. Detection of axillary lymphadenopathy after Covid-19 vaccination during breast examination: Case series and review of the literature after one year.
Veverková L; Mohelníková-Duchoňová B; Sedláčková Z; Löwová Ľ; Šišola I
Cent Eur J Public Health; 2023 Jun; 31(2):110-114. PubMed ID: 37451243
[TBL] [Abstract][Full Text] [Related]
18. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine associated axillary lymphadenopathy - A systematic review.
Co M; Wong PCP; Kwong A
Cancer Treat Res Commun; 2022; 31():100546. PubMed ID: 35334408
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]